Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Geron's enterprise value was $398.14M on Nov 11, 2026, against $434.31M a year earlier. Over the last 5 years it ranged from $218.98M to $2.61B, with a median of $725.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $398.14M | -17.2% |
| 2025 | Dec 31, 2025 | $480.96M | -75.6% |
| 2024 | Dec 31, 2024 | $1.97B | +139.9% |
| 2023 | Dec 29, 2023 | $821.02M | +10.0% |
| 2022 | Dec 30, 2022 | $746.56M | +193.1% |
| 2021 | Dec 31, 2021 | $254.67M | +41.8% |
| 2020 | Dec 31, 2020 | $179.66M | +55.0% |
| 2019 | Dec 31, 2019 | $115.89M | +3401.6% |
| 2018 | Dec 31, 2018 | $3.31M | -98.8% |
| 2017 | Dec 29, 2017 | $276.61M | -15.0% |
| 2016 | Dec 30, 2016 | $325.50M | -56.7% |
| 2015 | Dec 31, 2015 | $752.05M | +60.5% |
| 2014 | Dec 31, 2014 | $468.61M | -21.5% |
| 2013 | Dec 31, 2013 | $596.79M | +267.8% |
| 2012 | Dec 31, 2012 | $162.27M | -61.9% |
| 2011 | Jul 29, 2011 | $426.10M | – |
See a number that looks wrong?